eScholarship
metadata only
Bridging Tumor Genomics to Patient Outcomes Through an Integrated Patient-Derived Xenograft Platform
New approaches to optimization of cancer drug development in the laboratory and the clinic will be required to fully achieve the goal of individualized, precision cancer therapy. Improved preclinical models that more closely reflect the now recognized genomic complexity of human cancers are needed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma#967468
- QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy#897746
- Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial#340961
- Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo#983707
- Transforming Cancer Care: Genomic Profiling, AI, and Next-Generation Drug Delivery Systems.#483399
Record · ID 1341222
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive